Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Carbone

Showing results (131-140 of 167) with videos related to

Pageof 17
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2016
Improving the Accuracy of Mesothelioma Diagnosis in ChinaZhenying Guo, Michele Carbone, Xing Zhang, et al.
Journal of Translational Medicine|September 1, 2012
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITsMichele Carbone, Laura Korb Ferris, Francine Baumann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2016
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural MesotheliomaHarvey I Pass, Chandra Goparaju, Osvaldo Espin-Garcia, et al.
Oncotarget|February 11, 2017
HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesotheliomaLaura Pellegrini, Jiaming Xue, David Larson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2011
Erionite exposure in North Dakota and Turkish villages with mesotheliomaMichele Carbone, Y Izzettin Baris, Pietro Bertino, et al.
The New England Journal of Medicine|October 12, 2012
Fibulin-3 as a blood and effusion biomarker for pleural mesotheliomaHarvey I Pass, Stephen M Levin, Michael R Harbut, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2020
Asbestos induces mesothelial cell transformation via HMGB1-driven autophagyJiaming Xue, Simone Patergnani, Carlotta Giorgi, et al.
Human Vaccines & Immunotherapeutics|June 5, 2015
Preclinical development of HIvax: Human survivin highly immunogenic vaccinesPeter R Hoffmann, Maddalena Panigada, Elisa Soprana, et al.
Journal of Translational Medicine|December 5, 2014
Evaluation of clonal origin of malignant mesotheliomaSabahattin Comertpay, Sandra Pastorino, Mika Tanji, et al.
Nature Communications|October 24, 2018
Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1Salima Daou, Haithem Barbour, Oumaima Ahmed, et al.
Pageof 17

Showing results (131-140 of 167) with videos related to

Sort By:
Pageof 17
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 24, 2016
Improving the Accuracy of Mesothelioma Diagnosis in ChinaZhenying Guo, Michele Carbone, Xing Zhang, et al.
Journal of Translational Medicine|September 1, 2012
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITsMichele Carbone, Laura Korb Ferris, Francine Baumann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 24, 2016
Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural MesotheliomaHarvey I Pass, Chandra Goparaju, Osvaldo Espin-Garcia, et al.
Oncotarget|February 11, 2017
HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesotheliomaLaura Pellegrini, Jiaming Xue, David Larson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2011
Erionite exposure in North Dakota and Turkish villages with mesotheliomaMichele Carbone, Y Izzettin Baris, Pietro Bertino, et al.
The New England Journal of Medicine|October 12, 2012
Fibulin-3 as a blood and effusion biomarker for pleural mesotheliomaHarvey I Pass, Stephen M Levin, Michael R Harbut, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2020
Asbestos induces mesothelial cell transformation via HMGB1-driven autophagyJiaming Xue, Simone Patergnani, Carlotta Giorgi, et al.
Human Vaccines & Immunotherapeutics|June 5, 2015
Preclinical development of HIvax: Human survivin highly immunogenic vaccinesPeter R Hoffmann, Maddalena Panigada, Elisa Soprana, et al.
Journal of Translational Medicine|December 5, 2014
Evaluation of clonal origin of malignant mesotheliomaSabahattin Comertpay, Sandra Pastorino, Mika Tanji, et al.
Nature Communications|October 24, 2018
Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1Salima Daou, Haithem Barbour, Oumaima Ahmed, et al.
Pageof 17